Evolution of Evidence-Based Outcomes for Percutaneous Management

Matthew J. O'Shaughnessy; David A. Leavitt; J. Kyle Anderson

doi:10.1002/9781118670903.ch23

Evolution of Evidence-Based Outcomes for Percutaneous Management

Matthew J. O'Shaughnessy, David A. Leavitt, J. Kyle Anderson

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Percutaneous ablation has been developed over the last two decades to provide a minimally invasive treatment option for patients with renal masses. Despite increased use of this technology, data on percutaneous ablation are largely limited to observational studies with little significant comparison with other treatment options. Within these limitations, percutaneous ablation is proving to be a very viable alternative for selected patients, especially those with small renal masses and/or comorbidities that may limit more invasive treatments.

Original language	English (US)
Title of host publication	Percutaneous Renal Surgery
Publisher	Wiley
Pages	215-223
Number of pages	9
ISBN (Electronic)	9781118670903
ISBN (Print)	9781118278734
DOIs	https://doi.org/10.1002/9781118670903.ch23
State	Published - Oct 28 2013

Bibliographical note

Publisher Copyright:
© 2014 by John Wiley & Sons, Ltd. All rights reserved.

Keywords

Cryoablation
Kidney cancer
Radiofrequency ablation
Renal cell carcinoma

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1002/9781118670903.ch23

Find It

Find It at U of M Libraries

Cite this

@inbook{ccc32c629a02414b8b1bb488ce504fdf,

title = "Evolution of Evidence-Based Outcomes for Percutaneous Management",

abstract = "Percutaneous ablation has been developed over the last two decades to provide a minimally invasive treatment option for patients with renal masses. Despite increased use of this technology, data on percutaneous ablation are largely limited to observational studies with little significant comparison with other treatment options. Within these limitations, percutaneous ablation is proving to be a very viable alternative for selected patients, especially those with small renal masses and/or comorbidities that may limit more invasive treatments.",

keywords = "Cryoablation, Kidney cancer, Radiofrequency ablation, Renal cell carcinoma",

author = "O'Shaughnessy, {Matthew J.} and Leavitt, {David A.} and Anderson, {J. Kyle}",

year = "2013",

month = oct,

day = "28",

doi = "10.1002/9781118670903.ch23",

language = "English (US)",

isbn = "9781118278734",

pages = "215--223",

booktitle = "Percutaneous Renal Surgery",

publisher = "Wiley",

}

TY - CHAP

T1 - Evolution of Evidence-Based Outcomes for Percutaneous Management

AU - O'Shaughnessy, Matthew J.

AU - Leavitt, David A.

AU - Anderson, J. Kyle

PY - 2013/10/28

Y1 - 2013/10/28

N2 - Percutaneous ablation has been developed over the last two decades to provide a minimally invasive treatment option for patients with renal masses. Despite increased use of this technology, data on percutaneous ablation are largely limited to observational studies with little significant comparison with other treatment options. Within these limitations, percutaneous ablation is proving to be a very viable alternative for selected patients, especially those with small renal masses and/or comorbidities that may limit more invasive treatments.

AB - Percutaneous ablation has been developed over the last two decades to provide a minimally invasive treatment option for patients with renal masses. Despite increased use of this technology, data on percutaneous ablation are largely limited to observational studies with little significant comparison with other treatment options. Within these limitations, percutaneous ablation is proving to be a very viable alternative for selected patients, especially those with small renal masses and/or comorbidities that may limit more invasive treatments.

KW - Cryoablation

KW - Kidney cancer

KW - Radiofrequency ablation

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=85027228218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027228218&partnerID=8YFLogxK

U2 - 10.1002/9781118670903.ch23

DO - 10.1002/9781118670903.ch23

M3 - Chapter

AN - SCOPUS:85027228218

SN - 9781118278734

SP - 215

EP - 223

BT - Percutaneous Renal Surgery

PB - Wiley

ER -

Evolution of Evidence-Based Outcomes for Percutaneous Management

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this